the interaction of peptides and proteins with nanostructures surfaces a challenge for nanoscience

Abstract The impact of nanotechnologies in biomedicine and biotechnology is becoming more and more evident. It imposes practical challenges, for instance, raising specific issues on the biocompatibility of nanostructures. Nanoparticles are characterized by a high surface-to-volume ratio, which makes them reactive to foreign species. Thus, when proteins or peptides approach an inorganic nanoparticle, as well as a flat surface, they are likely to interact with the substrate to some extent. This interaction is crucial for applications in drug delivery, imaging, diagnostics, implants, and other medical devices. Specifically, gold nanoparticles are highly versatile and particularly appealing. It is widely accepted that the surfaces of nanoparticles adsorb proteins either transiently in the soft corona layer or permanently in the hard corona layer. As a consequence, the protein structure and/or function may undergo profound adjustments or remain conserved. Detailing the interaction of different inorganic substrates with proteins and peptides at the atomic level, and designing ways to control the interaction, is the key for biomedical applications of nanoparticles, both from a fundamental viewpoint and for practical implementations. In the last decade, we have addressed protein–nanoparticle interactions, focusing on interfaces of gold surfaces and nanoparticles with amyloidogenic peptides and protein models. We have developed classical force fields, performed advanced molecular dynamics simulations, and compared computational outcomes with data from nuclear magnetic resonance experiments. Protein–gold complexes with differently coated gold nanoparticles have been modeled to explore the effects of charge and size on the protein structure. Our work unravels that a complex interplay between surface properties and characteristics of the biological adsorbate determines whether peptide conformation is influenced and whether protein aggregation is accelerated or inhibited by the presence of the substrate. General guidelines to cope with amyloidogenic proteins could be inferred: these can be essentially summarized with the necessity of balancing the hydrophobic and electrostatic interactions that the amyloidogenic proteins establish with the coating moieties

Performance evaluation of detector for digital radiography

Lo scopo di questo lavoro è la caratterizzazione fisica del flat panel PaxScan4030CB Varian, rivelatore di raggi X impiegato in un ampio spettro di applicazioni cliniche, dalla radiografia generale alla radiologia interventistica. Nell’ambito clinico, al fine di una diagnosi accurata, è necessario avere una buona qualità dell’immagine radiologica mantenendo il più basso livello di dose rilasciata al paziente. Elemento fondamentale per ottenere questo risultato è la scelta del rivelatore di radiazione X, che deve garantire prestazioni fisiche (contrasto, risoluzione spaziale e rumore) adeguati alla specifica procedura. Le metriche oggettive che misurano queste caratteristiche sono SNR (Signal-to-Noise Ratio), MTF (Modulation Transfer Function) ed NPS (Noise Power Spectrum), che insieme contribuiscono alla misura della DQE (Detective Quantum Efficiency), il parametro più completo e adatto a stabilire le performance di un sistema di imaging. L’oggettività di queste misure consente anche di mettere a confronto tra loro diversi sistemi di rivelazione. La misura di questi parametri deve essere effettuata seguendo precisi protocolli di fisica medica, che sono stati applicati al rivelatore PaxScan4030CB presente nel laboratorio del Centro di Coordinamento di Fisica Medica, Policlinico S.Orsola. I risultati ottenuti, conformi a quelli dichiarati dal costruttore, sono stati confrontati con successo con alcuni lavori presenti in letteratura e costituiscono la base necessaria per la verifica di procedure di ottimizzazione dell’immagine radiologica attraverso interventi sul processo di emissione dei raggi X e sul trattamento informatico dell’immagine (Digital Subtraction Angiography)

Proline isomerization effects in the amyloidogenic protein β₂-microglobulin

none4noThe protein β2-microglobulin (β2-m) can aggregate in insoluble amyloid fibrils, which deposit in the skeletal muscle system of patients undergoing long-term haemodialysis. The molecular mechanisms of such amyloidogenesis are still not fully understood. A potential, although debated, triggering factor is the cis to trans isomerization of a specific proline (Pro32) in β2-m. Here we investigate this process in the native protein and in the aggregation-prone mutant D76N by means of molecular dynamics and the enhanced sampling method metadynamics. Our simulations, including the estimation of the free energy difference between the cis and trans isomers, are in good agreement with in vitro experiments and highlight the importance of the hydrogen bond and hydrophobic interaction network around the critical Pro32 in stabilizing and de-stabilizing the two isomers.noneMaschio M.C.; Fregoni J.; Molteni C.; Corni S.Maschio, M. C.; Fregoni, J.; Molteni, C.; Corni, S

Citrate stabilized gold nanoparticles interfere with amyloid fibril formation: D76N and \uce\u94n6 \uce\ub22-microglobulin variants

Protein aggregation including the formation of dimers and multimers in solution, underlies an array of human diseases such as systemic amyloidosis which is a fatal disease caused by misfolding of native globular proteins damaging the structure and function of affected organs. Different kind of interactors can interfere with the formation of protein dimers and multimers in solution. A very special class of interactors are nanoparticles thanks to the extremely efficient extension of their interaction surface. In particular citrate-coated gold nanoparticles (cit-AuNPs) were recently investigated with amyloidogenic protein $\beta$2-microglobulin ($\beta$2m). Here we present the computational studies on two challenging models known for their enhanced amyloidogenic propensity, namely $\Delta$N6 and D76N $\beta$2m naturally occurring variants, and disclose the role of cit-AuNPs on their fibrillogenesis. The proposed interaction mechanism lies in the interference of the cit-AuNPs with the protein dimers at the early stages of aggregation, that induces dimer disassembling. As a consequence, natural fibril formation can be inhibited. Relying on the comparison between atomistic simulations at multiple levels (enhanced sampling molecular dynamics and Brownian dynamics) and protein structural characterisation by NMR, we demonstrate that the cit-AuNPs interactors are able to inhibit protein dimer assembling. As a consequence, the natural fibril formation is also inhibited, as found in experiment.Comment: Published by RSC, under a Creative Commons Attribution 3.0 Unported Licenc